Genetic and epigenetic contribution to astrocytic gliomas pathogenesis-Reference-Cited by-同舟云学术

Genetic and epigenetic contribution to astrocytic gliomas pathogenesis

Published:2018-12-03 Issue:2 Volume:148 Page:188-203
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Khani Pouria¹²^ORCID,Nasri Farzad³,Khani Chamani Fateme⁴,Saeidi Farzane⁵,Sadri Nahand Javid⁶,Tabibkhooei Alireza⁷,Mirzaei Hamed⁸^ORCID

Affiliation:

1. Department of Medical Genetics and Molecular Biology; Faculty of Medicine; Iran University of Medical Sciences (IUMS); Tehran Iran

2. Student Research Committee; Iran University of Medical Sciences; Tehran Iran

3. Department of Medical Immunology; Faculty of Medicine; Iran University of Medical Sciences (IUMS); Tehran Iran

4. Department of Immunology; School of Medicine; Shahid Beheshti University of Medical Sciences; Tehran Iran

5. Department of Medical Genetics; School of Medical Sciences; Tarbiat Modares University; Tehran Iran

6. Department of Virology; Faculty of Medicine; Iran University of Medical Sciences; Tehran Iran

7. Department of Neurosurgery; Iran University of Medical Sciences; Tehran Iran

8. Research Center for Biochemistry and Nutrition in Metabolic Diseases; Kashan University of Medical Sciences; Kashan Iran

Funder

Kashan University of Medical Sciences

Iran University of Medical Sciences

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jnc.14616/fullpdf

Reference161 articles.

1. Expression of the epidermal growth factor receptor in astrocytic tumours is specifically associated with glioblastoma multiforme;Agosti;Virchows Arch. A Pathol. Anat. Histopathol.,1992

2. Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q;Albarosa;Am. J. Hum. Genet.,1996

3. Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance;Aldape;J. Neuropathol. Exp. Neurol.,2004

4. p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing;Badiali;Diagn. Mol. Pathol.,1993

5. Analysis of the IDH1 codon 132 mutation in brain tumors;Balss;Acta Neuropathol.,2008

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights on genetics and epigenetics as clinical targets for paediatric astrocytoma;Clinical and Translational Medicine;2024-02

2. MicroRNA-155 and cancer metastasis: Regulation of invasion, migration, and epithelial-to-mesenchymal transition;Pathology - Research and Practice;2023-10

3. Systemic lupus erythematosus: From non-coding RNAs to exosomal non-coding RNAs;Pathology - Research and Practice;2023-07

4. RB1‑promoter methylation in glioblastoma: A rare event in glioblastoma;Oncology Reports;2023-06-02

5. Role of non-coding RNAs in neuroblastoma;Cancer Gene Therapy;2023-05-22